The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications

Alfredo Iacoangeli, Allison A. Dilliott, Ahmad Al Khleifat, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Yossef Lerner, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip Van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Project MinE ALS Sequencing Consortium, Richard JB Dobson, Guy A. Rouleau, Ammar Al Chalabi, Sali M.K. Farhan
doi: https://doi.org/10.1101/2024.03.21.24304693

Article Information

doi 
https://doi.org/10.1101/2024.03.21.24304693
History 
  • March 26, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Alfredo Iacoangeli1,2,3,$,#,*,
  2. Allison A. Dilliott4,5,*,
  3. Ahmad Al Khleifat2,
  4. Peter M Andersen6,
  5. Nazli A. Başak7,
  6. Johnathan Cooper-Knock8,
  7. Philippe Corcia9,10,
  8. Philippe Couratier11,12,
  9. Mamede de Carvalho13,
  10. Vivian Drory14,15,
  11. Jonathan D. Glass16,
  12. Marc Gotkine17,18,
  13. Yossef Lerner17,18,
  14. Orla Hardiman19,
  15. John E. Landers20,
  16. Russell McLaughlin21,
  17. Jesús S. Mora Pardina22,
  18. Karen E. Morrison23,
  19. Susana Pinto13,
  20. Monica Povedano24,
  21. Christopher E. Shaw2,
  22. Pamela J. Shaw8,
  23. Vincenzo Silani25,26,
  24. Nicola Ticozzi25,26,
  25. Philip Van Damme27,28,
  26. Leonard H. van den Berg29,
  27. Patrick Vourc’h9,30,
  28. Markus Weber31,
  29. Jan H. Veldink29,
  30. Project MinE ALS Sequencing Consortium,
  31. Richard JB Dobson1,
  32. Guy A. Rouleau4,5,32,
  33. Ammar Al Chalabi2,33,34,+ and
  34. Sali M.K. Farhan4,5,32,$,#+
  1. 1Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
  2. 2Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
  3. 3Perron Institute for Neurological and Translational Science, University of Western Australia Medical School, Perth, Australia
  4. 4Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
  5. 5Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec
  6. 6Department of Clinical Science, Umeå University, Umeå SE-901 85, Sweden
  7. 7Koc University, School of Medicine, Translational Medicine Research Center, NDAL, Istanbul, 34450, Turkey
  8. 8Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK
  9. 9UMR 1253, Université de Tours, Inserm, Tours 37044, France
  10. 10Centre de référence sur la SLA, CHU de Tours, Tours 37044, France
  11. 11Centre de référence sur la SLA, CHRU de Limoges, Limoges, France
  12. 12UMR 1094, Université de Limoges, Inserm, Limoges 87025, France
  13. 13Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal
  14. 14Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv 64239, Israel
  15. 15Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel
  16. 16Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, GA 30322, USA
  17. 17Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel
  18. 18Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel
  19. 19Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02 PN40, Ireland
  20. 20Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA
  21. 21Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland
  22. 22ALS Unit, Hospital Universitario San Rafael, Madrid, Spain
  23. 23School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast BT9 7BL, UK
  24. 24Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona 08907, Spain
  25. 25Department of Neurology and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan 20149, Italy
  26. 26Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan 20122, Italy
  27. 27Department of Neuroscience, Leuven Brain Institute (LBI), VIB, Center for Brain and Disease Research, University of Leuven (KU Leuven), Leuven, Belgium
  28. 28University Hospitals Leuven, Department of Neurology, Leuven 3000, Belgium
  29. 29Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht 3584 CX, Netherlands
  30. 30Service de Biochimie et Biologie molécularie, CHU de Tours, Tours 37044, France
  31. 31Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland
  32. 32Department of Genetics, McGill University, Montreal, Quebec
  33. 33National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King’s College London, London, UK
  34. 34Department of Neurology, King’s College Hospital, London, UK
  1. ↵$Corresponding Authors:
    Sali M. K. Farhan Departments of Neurology and Neurosurgery, and Human Genetics Montreal Neurological Institute-Hospital, McGill University Montréal, QC, H4A 3J1 Email: sali.farhan{at}mcgill.ca Alfredo Iacoangeli Department of Biostatistics and Health Informatics, King’s College London Room 2.07 second floor | Social, Genetic and Developmental Psychiatry Centre (MRC) | Institute of Psychiatry, Psychology and Neuroscience | De Crespigny Park, Denmark Hill, London, United Kingdom, SE5 8AF Email: alfredo.iacoangeli{at}kcl.ac.uk
Back to top
Posted March 26, 2024.
Download PDF
Data/Code
Email
The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications
Alfredo Iacoangeli, Allison A. Dilliott, Ahmad Al Khleifat, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Yossef Lerner, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip Van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Project MinE ALS Sequencing Consortium, Richard JB Dobson, Guy A. Rouleau, Ammar Al Chalabi, Sali M.K. Farhan
medRxiv 2024.03.21.24304693; doi: https://doi.org/10.1101/2024.03.21.24304693
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area